These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20401552)

  • 1. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study.
    Ravens-Sieberer U; Wille N; Badia X; Bonsel G; Burström K; Cavrini G; Devlin N; Egmar AC; Gusi N; Herdman M; Jelsma J; Kind P; Olivares PR; Scalone L; Greiner W
    Qual Life Res; 2010 Aug; 19(6):887-97. PubMed ID: 20401552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.
    Scott D; Ferguson GD; Jelsma J
    Health Qual Life Outcomes; 2017 Jan; 15(1):12. PubMed ID: 28103872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
    Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
    Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability.
    Downs J; Norman R; Mulhern B; Jacoby P; Reddihough D; Choong CS; Finlay-Jones A; Blackmore AM
    Value Health; 2024 Jun; 27(6):776-783. PubMed ID: 38467188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validity and reliability of the spanish EQ-5D-Y proxy version].
    Gusi N; Perez-Sousa MA; Gozalo-Delgado M; Olivares PR
    An Pediatr (Barc); 2014 Oct; 81(4):212-9. PubMed ID: 24411558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity.
    Shiroiwa T; Fukuda T; Shimozuma K
    Qual Life Res; 2019 Nov; 28(11):3093-3105. PubMed ID: 31243620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D.
    Wille N; Badia X; Bonsel G; Burström K; Cavrini G; Devlin N; Egmar AC; Greiner W; Gusi N; Herdman M; Jelsma J; Kind P; Scalone L; Ravens-Sieberer U
    Qual Life Res; 2010 Aug; 19(6):875-86. PubMed ID: 20405245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring preference-based quality of life in children aged 6-7 years: a comparison of the performance of the CHU-9D and EQ-5D-Y--the WAVES pilot study.
    Canaway AG; Frew EJ
    Qual Life Res; 2013 Feb; 22(1):173-83. PubMed ID: 22302618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.
    Mayoral K; Rajmil L; Murillo M; Garin O; Pont A; Alonso J; Bel J; Perez J; Corripio R; Carreras G; Herrero J; Mengibar JM; Rodriguez-Arjona D; Ravens-Sieberer U; Raat H; Serra-Sutton V; Ferrer M
    J Med Internet Res; 2019 Nov; 21(11):e14947. PubMed ID: 31714252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the EQ-5D in a general population sample in urban China.
    Wang HM; Patrick DL; Edwards TC; Skalicky AM; Zeng HY; Gu WW
    Qual Life Res; 2012 Feb; 21(1):155-60. PubMed ID: 21505881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.
    Fang H; Farooq U; Wang D; Yu F; Younus MI; Guo X
    Springerplus; 2016; 5(1):1924. PubMed ID: 27917330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney disease.
    Hsu CN; Lin HW; Pickard AS; Tain YL
    Int J Qual Health Care; 2018 May; 30(4):298-305. PubMed ID: 29447362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity and reliability of the interviewer-administered EQ-5D-Y-3L version in young children.
    Amien R; Scott D; Verstraete J
    Health Qual Life Outcomes; 2023 Feb; 21(1):19. PubMed ID: 36814254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
    Eidt-Koch D; Mittendorf T; Greiner W
    BMC Pediatr; 2009 Aug; 9():55. PubMed ID: 19715563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the web-based Spanish and Catalan versions of the Euroqol 5D-Y (EQ-5D-Y) and comparison of results with the paper version.
    Robles N; Rajmil L; Rodriguez-Arjona D; Azuara M; Codina F; Raat H; Ravens-Sieberer U; Herdman M
    Health Qual Life Outcomes; 2015 Jun; 13():72. PubMed ID: 26037720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis.
    Gualtierotti R; Ingegnoli F; Scalone L; Cortesi P; Bruschi E; Gerosa M; Meroni PL
    Swiss Med Wkly; 2016; 146():w14394. PubMed ID: 28102877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity.
    Badia X; Schiaffino A; Alonso J; Herdman M
    Qual Life Res; 1998 May; 7(4):311-22. PubMed ID: 9610215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
    Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility, validity and reliability of the Welsh version of the EQ-5D health status questionnaire.
    Hughes DA
    Qual Life Res; 2007 Oct; 16(8):1419-23. PubMed ID: 17653613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.